Trial Information
Phase III Randomized Controlled Trial of a Collaborative Care Intervention to Manage Cancer Related Symptoms in Patients Diagnosed With Hepatobiliary Carcinoma
The study is a collaborative care intervention designed to reduce pain, fatigue, and
depressive symptoms and improve overall health related quality of life.
Inclusion Criteria:
- biopsy, radiological, and/or biological evidence of hepatobiliary carcinoma
- age 18 years or older
- fluency in English. Exclusion criteria included:
Exclusion Criteria:
- current suicidal or homicidal ideation
- current psychosis or thought disorder
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care
Outcome Measure:
Depression
Outcome Description:
Center for Epidemiological Studies-Depression scale
Outcome Time Frame:
Change from baseline at 6 and 12 months
Safety Issue:
No
Principal Investigator
Jennifer L Steel, Ph.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Pittsburgh
Authority:
United States: Institutional Review Board
Study ID:
PRO07050143
NCT ID:
NCT01640522
Start Date:
January 2008
Completion Date:
June 2013
Related Keywords:
- Hepatocellular Carcinoma
- Primary Liver Cancer
- Bile Duct Cancer
- Pancreatic Cancer
- Gallbladder Cancer
- Colorectal Carcinoma
- Liver Metastases
- Hepatocellular carcinoma
- Cholangio carcinoma
- Primary Liver Cancer
- Bile Duct CancerPancreatic Cancer
- Gallbladder Cancer
- Colorectal Carcinoma
- Other Primary Cancers with Liver Metastases
- Carcinoma
- Colorectal Neoplasms
- Liver Neoplasms
- Neoplasm Metastasis
- Pancreatic Neoplasms
- Gallbladder Neoplasms
- Bile Duct Neoplasms
- Carcinoma, Hepatocellular
Name | Location |
University of Pittsburgh Medical Center |
Pittsburgh, Pennsylvania 15213 |